» Articles » PMID: 28139655

A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review

Abstract

In this article, we review our multidisciplinary approach for patients with pancreatic cancer. Specifically, we review the epidemiology, diagnosis and staging, biliary drainage techniques, selection of patients for surgery, chemotherapy, radiation therapy, and discuss other palliative interventions. The areas of active research investigation and where our knowledge is limited are emphasized.

Citing Articles

An update on pancreatic cancer imaging, staging, and use of the PACT-UK radiology template pre- and post-neoadjuvant treatment.

Corallo C, Al-Adhami A, Jamieson N, Valle J, Radhakrishna G, Moir J Br J Radiol. 2024; 98(1165):13-26.

PMID: 39460945 PMC: 11652714. DOI: 10.1093/bjr/tqae217.


A novel nomogram based on the number of positive lymph nodes can predict the overall survival of patients with pancreatic head cancer after radical surgery.

You K, Lei K, Wang X, Hu R, Zhang H, Xu J World J Surg Oncol. 2024; 22(1):241.

PMID: 39245733 PMC: 11382414. DOI: 10.1186/s12957-024-03519-x.


Pancreatic Ductal Adenocarcinoma: Update of CT-Based Radiomics Applications in the Pre-Surgical Prediction of the Risk of Post-Operative Fistula, Resectability Status and Prognosis.

Pacella G, Brunese M, DImperio E, Rotondo M, Scacchi A, Carbone M J Clin Med. 2023; 12(23).

PMID: 38068432 PMC: 10707069. DOI: 10.3390/jcm12237380.


The impact of a multidisciplinary team approach on the management of focal pancreatic lesions: a single tertiary center experience.

Francisse S, Gkolfakis P, Fernandez Y Viesca M, Mans L, Demols A, Pezzullo M Ann Gastroenterol. 2023; 36(5):580-587.

PMID: 37664233 PMC: 10433261. DOI: 10.20524/aog.2023.0827.


Impact of Preoperative Tumor Size on Prognosis of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinomas.

Miyata Y, Yonamine N, Fujinuma I, Tsunenari T, Takihata Y, Hakoda H Ann Surg Oncol. 2023; 30(13):8621-8630.

PMID: 37658273 DOI: 10.1245/s10434-023-14219-3.


References
1.
Herman J, Chang D, Goodman K, Dholakia A, Raman S, Hacker-Prietz A . Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. Cancer. 2014; 121(7):1128-37. PMC: 4368473. DOI: 10.1002/cncr.29161. View

2.
Morita T, Akechi T, Ikenaga M, Kizawa Y, Kohara H, Mukaiyama T . Late referrals to specialized palliative care service in Japan. J Clin Oncol. 2005; 23(12):2637-44. DOI: 10.1200/JCO.2005.12.107. View

3.
Lee J, Krishna S, Singh A, Ladha H, Slack R, Ramireddy S . Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in 749 patients. Gastrointest Endosc. 2013; 78(2):312-24. DOI: 10.1016/j.gie.2013.02.032. View

4.
Asbun H, Conlon K, Fernandez-Cruz L, Friess H, Shrikhande S, Adham M . When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery. Surgery. 2014; 155(5):887-92. DOI: 10.1016/j.surg.2013.12.032. View

5.
Wyse J, Carone M, Paquin S, Usatii M, Sahai A . Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer. J Clin Oncol. 2011; 29(26):3541-6. DOI: 10.1200/JCO.2010.32.2750. View